title: Cardiometabolic risk factors related to vitamin d and adiponectin in obese children and adolescents.
abstract: Obesity-related diseases are becoming the most important causes of mortality worldwide. Several studies have suggested an association between low levels of vitamin D and obesity. In addition, plasma adiponectin levels have been found to be lower in obese subjects. We evaluated the association of metabolic risk factors with both adiponectin and vitamin D levels and that between adiponectin and vitamin D levels. The study consisted of 114 obese and healthy subjects. 25-Hydroxy vitamin D [25(OH)D] levels were positively correlated with adiponectin and HDL-cholesterol (HDL-C) and inversely correlated with body mass index (BMI), LDL-cholesterol (LDL-C), total cholesterol (T-C), triglyceride (TG), fasting glucose, homeostasis model assessment of insulin resistance (HOMA index), systolic blood pressure (SBP), and diastolic blood pressure (DBP). The mean 25(OH)D levels in the obese and nonobese groups were 22.5 ± 5.7 and 32.3 ± 5.8 ng/mL, respectively (P < 0.0001). The mean adiponectin level in the obese group was lower than that in the nonobese group (P < 0.0001). Lower vitamin D and adiponectin levels were strongly associated with metabolic risk factors and obesity in Turkish children and adolescents.
authors: Department of Paediatric Metabolism, Erciyes University, School of Medicine, 38039 Kayseri, Turkey.
authors: Fatih
authors: F
authors: Kardas
authors: Mustafa
authors: M
authors: Kendirci
authors: Selim
authors: S
authors: Kurtoglu
references: Arch Intern Med. 2008 Aug 11;168(15):1629-37
references: 18695076
references: Am J Clin Nutr. 2009 Sep;90(3):459-67
references: 19640956
references: J Biol Chem. 2002 Oct 4;277(40):37487-91
references: 12138120
references: Am J Clin Nutr. 2000 Sep;72(3):690-3
references: 10966885
references: Pediatrics. 2009 Sep;124(3):e371-9
references: 19661053
references: N Engl J Med. 2007 Jul 19;357(3):266-81
references: 17634462
references: Am J Hypertens. 1995 Sep;8(9):894-901
references: 8541004
references: Arch Dis Child. 2011 May;96(5):447-52
references: 21335626
references: Metabolism. 2004 Dec;53(12):1522-6
references: 15562393
references: Obes Surg. 1993 Nov;3(4):421-424
references: 10757956
references: J Pediatr Endocrinol Metab. 2008 Sep;21(9):827-36
references: 18924576
references: Am J Hypertens. 2013 Feb;26(2):257-64
references: 23382411
references: Med J Aust. 2007 Jul 2;187(1):59-60
references: 17605716
references: Diabetes. 2008 Feb;57(2):298-305
references: 18003755
references: Eur J Endocrinol. 2009 Jun;160(6):965-71
references: 19289535
references: J Mol Med (Berl). 2002 Nov;80(11):696-702
references: 12436346
references: Obesity (Silver Spring). 2007 Feb;15(2):340-8
references: 17299106
references: Arch Intern Med. 2008 Jun 9;168(11):1174-80
references: 18541825
references: J Clin Invest. 2002 Jul;110(2):229-38
references: 12122115
references: Metabolism. 2008 Feb;57(2):183-91
references: 18191047
references: Curr Pharm Des. 2010 Oct;16(30):3417-34
references: 20819071
references: Diabetes. 2002 Jun;51(6):1884-8
references: 12031977
references: Eur J Endocrinol. 2008 Jul;159(1):41-8
references: 18426812
references: J Clin Endocrinol Metab. 2009 Sep;94(9):3200-6
references: 19549742
references: Hypertension. 2007 May;49(5):1063-9
references: 17372031
references: Cytokine Growth Factor Rev. 2003 Oct;14(5):447-55
references: 12948526
references: J Am Soc Nephrol. 2009 Dec;20(12):2631-9
references: 19875805
references: Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):29-33
references: 14551151
references: J Rheumatol Suppl. 2005 Sep;76:11-20
references: 16142846
references: Lancet. 2002 Jul 6;360(9326):57-8
references: 12114044
references: Am J Cardiol. 2010 Sep 15;106(6):798-805
references: 20816120
references: Cardiovasc Ther. 2010 Aug;28(4):e5-12
references: 20553279
references: J Hypertens. 1993 Nov;11(11):1267-74
references: 8301109